Belite Bio (BLTE) announced the pricing of an underwritten public offering of its American Depositary Shares ((ADSs)), to raise approximately $350.0 million in gross proceeds, before deducting offering expenses.
The company priced 2,272,727 ADSs —with each ADS representing one ordinary share—at
Source link
